News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,509 Results
Type
Article (42088)
Company Profile (261)
Press Release (670160)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (208026)
Career Advice (2055)
Deals (35815)
Drug Delivery (99)
Drug Development (82510)
Employer Resources (175)
FDA (16494)
Job Trends (15122)
News (351376)
Policy (33213)
Tag
Academia (2666)
Accelerated approval (5)
Adcomms (21)
Allergies (87)
Alliances (50968)
ALS (91)
Alzheimer's disease (1426)
Antibody-drug conjugate (ADC) (132)
Approvals (16495)
Artificial intelligence (270)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11791)
BIOSECURE Act (20)
Biosimilars (108)
Biotechnology (182)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (282)
Cancer (2306)
Cardiovascular disease (186)
Career advice (1723)
Career pathing (32)
CAR-T (157)
Cell therapy (438)
Cervical cancer (19)
Clinical research (67047)
Collaboration (872)
Compensation (529)
Complete response letters (21)
COVID-19 (2668)
CRISPR (44)
C-suite (250)
Cystic fibrosis (103)
Data (2227)
Decentralized trials (2)
Denatured (18)
Depression (47)
Diabetes (274)
Diagnostics (6496)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (125)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (87137)
Editorial (38)
Employer branding (22)
Employer resources (149)
Events (114359)
Executive appointments (737)
FDA (17785)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (776)
Gene editing (108)
Generative AI (25)
Gene therapy (317)
GLP-1 (735)
Government (4515)
Grass and pollen (5)
Guidances (65)
Healthcare (19135)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (128)
Indications (30)
Infectious disease (2814)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (97)
Interviews (316)
IPO (16602)
IRA (40)
Job creations (3755)
Job search strategy (1464)
Kidney cancer (11)
Labor market (38)
Layoffs (483)
Leadership (19)
Legal (8067)
Liver cancer (77)
Lung cancer (323)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (311)
MASH (69)
Medical device (13599)
Medtech (13604)
Mergers & acquisitions (19763)
Metabolic disorders (704)
Multiple sclerosis (83)
NASH (18)
Neurodegenerative disease (99)
Neuropsychiatric disorders (29)
Neuroscience (1984)
NextGen: Class of 2025 (6626)
Non-profit (4621)
Now hiring (39)
Obesity (375)
Opinion (210)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (85)
Parkinson's disease (153)
Partnered (21)
Patents (234)
Patient recruitment (116)
Peanut (46)
People (58742)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20954)
Phase II (29499)
Phase III (21964)
Pipeline (1225)
Policy (141)
Postmarket research (2606)
Preclinical (8948)
Press Release (67)
Prostate cancer (107)
Psychedelics (33)
Radiopharmaceuticals (250)
Rare diseases (392)
Real estate (6061)
Recruiting (67)
Regulatory (22758)
Reports (46)
Research institute (2430)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (70)
Series A (136)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (155)
Sponsored (30)
Startups (3697)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (39)
The Weekly (31)
Vaccines (705)
Venture capitalists (42)
Weight loss (247)
Women's health (35)
Worklife (16)
Date
Today (206)
Last 7 days (906)
Last 30 days (2692)
Last 365 days (33472)
2025 (10894)
2024 (35860)
2023 (40728)
2022 (51874)
2021 (56457)
2020 (54785)
2019 (47406)
2018 (35752)
2017 (32898)
2016 (32349)
2015 (38362)
2014 (32062)
2013 (27112)
2012 (29191)
2011 (29878)
2010 (27952)
Location
Africa (747)
Alabama (55)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38925)
Australia (6424)
California (6172)
Canada (2029)
China (534)
Colorado (268)
Connecticut (281)
Delaware (147)
Europe (85132)
Florida (913)
Georgia (208)
Idaho (57)
Illinois (548)
India (25)
Indiana (311)
Iowa (11)
Japan (164)
Kansas (105)
Kentucky (23)
Louisiana (10)
Maine (70)
Maryland (906)
Massachusetts (4652)
Michigan (221)
Minnesota (400)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (66)
New Jersey (1735)
New Mexico (30)
New York (1763)
North Carolina (1003)
North Dakota (9)
Northern California (2700)
Ohio (205)
Oklahoma (15)
Oregon (38)
Pennsylvania (1386)
Puerto Rico (13)
Rhode Island (34)
South America (1133)
South Carolina (24)
South Dakota (1)
Southern California (2313)
Tennessee (103)
Texas (912)
United States (23403)
Utah (184)
Virginia (148)
Washington D.C. (61)
Washington State (556)
West Virginia (3)
Wisconsin (55)
712,509 Results for "milestone scientific inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
April 15, 2025
·
8 min read
Complete response letters
Milestone Stock Crashes After Surprise Tachycardia Drug Rejection
Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular tachycardia when the FDA issued a Complete Response Letter on Friday.
March 28, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
November 15, 2024
·
10 min read
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
Policy
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announces that it has received regulatory approval from Brazil’s National Health Surveillance Agency (ANVISA) to market and sell its CompuFlo® Epidural System in Brazil.
June 18, 2024
·
4 min read
Business
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Milestone Scientific Inc. today provides a business update and announces financial results for the first quarter ended March 31, 2024.
May 16, 2024
·
9 min read
Business
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provides a business update and announces financial results for the year ending December 31, 2023.
April 1, 2024
·
10 min read
Press Releases
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
February 4, 2025
·
3 min read
Press Releases
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
March 20, 2025
·
3 min read
Press Releases
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck
February 12, 2025
·
4 min read
1 of 71,251
Next
